Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

Omicron variant

Ohio State logo

SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung

The Omicron subvariants BA.1, BA.4, BA.5 as well as Q.1.1 have a high number of mutations in the spike protein. Some of these mutations are escape mutations that allow the virus to escape neutralization by antibodies. In addition, resistance to biotechnologically produced antibodies, which are administered to high-risk patients as a preventive measure or as therapy for a diagnosed SARS-CoV-2 infection, is also developing. Omicron sub-lineage BQ.1.1 is the first variant resistant to all antibody therapies currently approved by the EMA (European Medicines Agency) and/or FDA (US Food and Drug Administration).

New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies

Substack subscription form sign up

Comments

  • Marco Messina on More Than a Third of Americans Have Lost Relationships Over Politics
  • Anon on Why Fructose Behaves Less Like a Calorie and More Like a Hormone
  • Mark Mellinger on Living Plastic Can Self-Destruct on Command
  • Marie Feret on The Silent Frequency That Makes Old Buildings Feel Haunted
  • Dax on The Silent Frequency That Makes Old Buildings Feel Haunted
© 2026 ScienceBlog.com | Follow our RSS / XML feed